2021
|
Question
[CLICK ON ANY CHOICE TO KNOW THE RIGHT ANSWER]
|
|
|
China
|
|
|
USA
|
|
|
Australia
|
|
|
UK
|
Detailed explanation-1: -Molnupiravir was developed at Emory University by its drug innovation company, Drug Innovation Ventures at Emory (DRIVE).
Detailed explanation-2: -The vaccine is administered in two doses that are given three weeks apart. In December 2020, the UK became the first country in the world to approve this vaccine and began rolling out an initial 800, 000 doses at the start of the month, and is now in use worldwide.
Detailed explanation-3: -The UK was the first country to authorise Merck Sharp and Dohme’s molnupiravir (Lagevrio) for the treatment of mild to moderate covid-19 in adults with at least one risk factor for severe illness, in November 2021.
Detailed explanation-4: -Merck and Ridgeback’s Molnupiravir, an Investigational Oral Antiviral COVID-19 Treatment, Receives Special Approval for Emergency in Japan.